Robuta

https://www.ncbi.nlm.nih.gov/Structure/pdb/3FX5
structurehivproteasecomplexpotent
https://www.mdpi.com/2077-0383/12/12/4094
Background: Purinergic signaling receptor Y12 (P2Y12) inhibitors are a fundamental part of pharmacological therapy in acute coronary syndrome (ACS) for...
high potentimpactpreclinicalinhibitorsdecision